These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 28461252)

  • 1. Cortisol in schizophrenia: No association with tobacco smoking, clinical symptoms or antipsychotic medication.
    Nedic Erjavec G; Uzun S; Nikolac Perkovic M; Kozumplik O; Svob Strac D; Mimica N; Hirasawa-Fujita M; Domino EF; Pivac N
    Prog Neuropsychopharmacol Biol Psychiatry; 2017 Jul; 77():228-235. PubMed ID: 28461252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Smoking and schizophrenia: is symptom profile related to smoking and which antipsychotic medication is of benefit in reducing cigarette use?
    Barnes M; Lawford BR; Burton SC; Heslop KR; Noble EP; Hausdorf K; Young RM
    Aust N Z J Psychiatry; 2006; 40(6-7):575-80. PubMed ID: 16756583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salivary cortisol concentrations are associated with acute nicotine withdrawal.
    Cohen LM; al'Absi M; Collins FL
    Addict Behav; 2004 Nov; 29(8):1673-8. PubMed ID: 15451136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of tobacco on antipsychotic treatments and their symptoms in schizophrenia].
    Bouhlel S; Jones Y; Msolly M; Ben Hawala S; El-Hechmi Z
    Tunis Med; 2012 Apr; 90(4):311-5. PubMed ID: 22535346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulatory neurosteroid levels in smoking and non-smoking chronic schizophrenia patients.
    Iancu I; Tchernihovsky E; Maayan R; Poreh A; Dannon P; Kotler M; Weizman A; Strous RD
    Eur Neuropsychopharmacol; 2007 Jul; 17(8):541-5. PubMed ID: 17346944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cortisol and cytokines in chronic and treatment-resistant patients with schizophrenia: association with psychopathology and response to antipsychotics.
    Zhang XY; Zhou DF; Cao LY; Wu GY; Shen YC
    Neuropsychopharmacology; 2005 Aug; 30(8):1532-8. PubMed ID: 15886721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tobacco use in schizophrenia: a study of cotinine concentrations in the saliva of patients and controls.
    Strand JE; Nybäck H
    Eur Psychiatry; 2005 Jan; 20(1):50-4. PubMed ID: 15642444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations between adrenocortical activity and nicotine response in female smokers by menstrual phase.
    Huttlin EA; Allen AM; Tosun NL; Allen SS; al'Absi M
    Addict Behav; 2015 Nov; 50():135-9. PubMed ID: 26135333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diurnal cortisol variation and cortisol response to an MRI stressor in schizophrenia and bipolar disorder.
    Girshkin L; O'Reilly N; Quidé Y; Teroganova N; Rowland JE; Schofield PR; Green MJ
    Psychoneuroendocrinology; 2016 May; 67():61-9. PubMed ID: 26874562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum cortisol and DHEA-S levels in schizophrenic patients with different response to antipsychotic therapy: association with psychopathology.
    Babinkostova Z; Stefanovski B; Janicevic-Ivanovska D; Samardziska V; Stojanovska L
    Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2015; 36(1):175-83. PubMed ID: 26076787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disrupted glucocorticoid--Immune interactions during stress response in schizophrenia.
    Chiappelli J; Shi Q; Kodi P; Savransky A; Kochunov P; Rowland LM; Nugent KL; Hong LE
    Psychoneuroendocrinology; 2016 Jan; 63():86-93. PubMed ID: 26431803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tobacco smoking is causally associated with antipsychotic medication use and schizophrenia, but not with antidepressant medication use or depression.
    Wium-Andersen MK; Ørsted DD; Nordestgaard BG
    Int J Epidemiol; 2015 Apr; 44(2):566-77. PubMed ID: 26054357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salivary cortisol in early psychosis: New findings and meta-analysis.
    Chaumette B; Kebir O; Mam-Lam-Fook C; Morvan Y; Bourgin J; Godsil BP; Plaze M; Gaillard R; Jay TM; Krebs MO
    Psychoneuroendocrinology; 2016 Jan; 63():262-70. PubMed ID: 26520686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of the Endogenous Stress Response System in Patients with Chronic Schizophrenia.
    Monteleone AM; Monteleone P; Di Filippo C; Pellegrino F; Grillo F; Maj M
    Neuropsychobiology; 2015; 72(1):1-7. PubMed ID: 26287549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association among serum cortisol, dehydroepiandrosterone-sulfate levels and psychiatric symptoms in men with chronic schizophrenia.
    Peng R; Li Y
    Compr Psychiatry; 2017 Jul; 76():113-118. PubMed ID: 28482249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A functional polymorphism in the interleukin-1beta and severity of nicotine dependence in male schizophrenia: a case-control study.
    Zhang XY; Chen DC; Tan YL; Tan SP; Luo X; Zuo L; Rao W; Yu Q; Kou C; Allen M; Correll CU; Wu J; Soares JC
    J Psychiatr Res; 2015 May; 64():51-8. PubMed ID: 25858413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Occupancy of dopamine D2 receptors by antipsychotic drugs is related to nicotine addiction in young patients with schizophrenia.
    de Haan L; Booij J; Lavalaye J; van Amelsvoort T; Linszen D
    Psychopharmacology (Berl); 2006 Jan; 183(4):500-5. PubMed ID: 16292589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevation of the cortisol/dehydroepiandrosterone ratio in schizophrenia patients.
    Ritsner M; Maayan R; Gibel A; Strous RD; Modai I; Weizman A
    Eur Neuropsychopharmacol; 2004 Aug; 14(4):267-73. PubMed ID: 15163435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Study of the Impact of Cannabis on Doses of Discharge Antipsychotic Medication in Individuals with Schizophrenia or Schizoaffective Disorder.
    Babatope T; Chotalia J; Elkhatib R; Mohite S; Shah J; Goddu S; Patel RA; Aimienwanu OR; Patel D; Makanjuola T; Okusaga OO
    Psychiatr Q; 2016 Dec; 87(4):729-737. PubMed ID: 26875104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stress induced by the socially evaluated cold-pressor test cause equivalent deficiencies of sensory gating in male subjects with schizophrenia and healthy controls.
    Rubio G; López-Muñoz F; Jurado-Barba R; Martínez-Gras I; Rodríguez-Jiménez R; Espinosa R; Pérez-Nieto MÁ; Moratti S; Jiménez-Arriero MÁ; Carlos Leza J
    Psychiatry Res; 2015 Aug; 228(3):283-8. PubMed ID: 26154819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.